Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

Presentation TCT 2017

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Presentation TCT 2017

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Presenter: Azeem Latib, Dean J. Kereiakes

October 31, 2017

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

Presentation TCT 2017

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

Presentation TCT 2017

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

Presenter: Azeem Latib, Bernard R. Chevalier

October 31, 2017

ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings

Presentation TCT 2017

ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings

Presenter: Azeem Latib, Manel Sabate

October 31, 2017

New Insights From AIDA: Subgroups and Predictors of Adverse Events

Presentation TCT 2017

New Insights From AIDA: Subgroups and Predictors of Adverse Events

Presenter: Azeem Latib, Joanna J. Wykrzykowska

October 31, 2017

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

News Conference News TCT 2017

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

October 30, 2017

TCTMD’s Top 10 Most Popular Stories for October 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

October 29, 2017

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

News Daily News

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

October 23, 2017

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

News Daily News

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

October 02, 2017

New-Generation DES Work Just Fine in Women With Acute MI

News Daily News

New-Generation DES Work Just Fine in Women With Acute MI

June 29, 2017

Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease

News Daily News

Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease

June 12, 2017

Beta-Blockers Questioned Anew in Post-MI Patients Without Heart Failure

News Daily News

Beta-Blockers Questioned Anew in Post-MI Patients Without Heart Failure

May 31, 2017

Benefits of FFR-Guided Complete Revascularization in STEMI May Be Limited to Most Severe Disease

News Daily News

Benefits of FFR-Guided Complete Revascularization in STEMI May Be Limited to Most Severe Disease

April 21, 2017

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

News Conference News ACC 2017

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

March 18, 2017

To Stent or Not to Stent? iFR vs FFR Late Breakers at ACC 2017 Seek to Shake Up Treatment Decisions

News Conference News ACC 2017

To Stent or Not to Stent? iFR vs FFR Late Breakers at ACC 2017 Seek to Shake Up Treatment Decisions

March 14, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.